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(Haleagrahara, et. al., 2011; Moreira, et. al., 
2001; Nriagu, et. al., 1997). Its ubiquity in the 
environment- the air, water, soil, food, 
among others makes it one of the leading 
metallic xenobiotic particularly in many de-
veloping countries (Koedrith and Young, 
2011; Oteiza, et. al., 2004; Sajitha, et. al., 2010; 
Shalan, et. al., 2005; Shehata, 2011).  
 
ABSTRACT 
Lead has been implicated in the induction of reactive species production, leading to organ dysfunc-
tions. The ameliorative roles of ascorbate and chelators in acute lead poisoning were comparatively 
studied in thirty-five male Wistar rats (150-200g), segregated into 5 groups (n=7/Group): group 1
(administered normal saline),  groups 2-5 were orally exposed to 75mg/kg body weight lead acetate 
(PbAc) daily for 14 days. Pre-therapy blood samples were collected to ascertain blood lead level (BLL) 
and catalase activity 24hours after the last PbAc exposure. Groups 3, 4, and 5 were then treated with 
30mg/kg body weight D-penicillamine; 30mg/kg body weight succimer; and 500mg/kg body weight 
ascorbate respectively for 10 days, followed by the assay for indices of oxidative stress, hepatic and 
renal dysfunctions.  Results obtained showed significantly elevated BLL in the four groups exposed to 
PbAc. which were significantly reversed about 2 folds in groups 3-5 after therapeutic interventions. Pre
-therapy blood catalase activity of the PbAc treated groups was significantly (p<0.05) reduced by 39% 
when compared with the control group, however ascorbate significantly (p<0.05) increased catalase 
activity by 2 folds above the control; decreased plasma activities of alanine transaminase and aspar-
tate transaminase, blood urea nitrogen and creatinine among the groups administered therapeutics. 
These findings indicate that ascorbate is more effective  
 
Key words: antioxidant, blood lead level (BLL), chelating agents, oxidative stress, plumbism,  
                     xenobiotic 
INTRODUCTION 
Lead is a heavy metal found in the earth 
crust usually in compound forms as angle-
site (PbSO4), cerusite (PbCO3), galena 
(PbS). Since ancient civilization, lead has 
been of widespread use and an insidious 
environmental toxin. It is sometimes known 
as a severe and aggressive contaminant `in 
human and animals’ health status 
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Lead is relatively poorly absorbed into and 
excreted from the body, moving into soft 
tissues and bones where it remains depos-
ited for a long time until therapeutic inter-
vention (Balali-Mood, 2010; Moreira, et. al., 
2001). The Centres for Disease Control and 
Prevention, (CDC), World Health Organi-
sation Occupational Safety and Health Ad-
ministration (WHO-OSHA) redefined ele-
vated blood lead levels (BLL) as that 
≥10µg/dl in children and 40µg/dl in adults. 
A notable route of lead poisoning 
(plumbism) beyond this safe level for chil-
dren is through ingestion, and most adults 
through occupational exposure (Payal, et. al., 
2009; Shehata, 2011; Sujatha, et. al., 2011; 
Tkachenko and Kurhahyuk, 2011). 
 
Widely known is the fact that heavy metals 
such as lead induce lipid peroxidation by 
the production of Reactive Oxygen Species 
(ROS) such as hydroxyl peroxide and super-
oxide radicals; and Reactive Nitrogen Spe-
cies (RNS) such as nitric oxide, peroxyni-
trite and S-nitrosothiols (Chen, et. al., 2003; 
Choudhary, et. al., 2007; Flora, et. al., 2004; 
Kumar, et. al., 2011). Often, these radicals 
have rendered oxidative damage to DNA, 
proteins and lipids. ROS and RNS often 
result to the decreased activity of antioxi-
dant enzymes such as catalase, superoxide 
dismutase, glutathione peroxidase and glu-
tathione reductase (Ibrahim, et. al., 2012; 
Sajitha, et. al., 2010; Shalan, et. al., 2005), 
which are also oxidative stress markers.  
 
Lead poisoning interferes with important 
metabolic activities such as the DNA repair 
system, thus inducing carcinogenicity (Patil, 
et. al., 2006; Ponce-Canchihuaman, et. al., 
2010), interferes with and suppress the 
Heme synthesis pathway by inhibiting the 
key enzymes including δ-aminolevulinic 
acid dehydratase and ferrochelatase, leading 
to anaemia in most cases (Ademuyiwa, et. al., 
2005; Costa, et. al., 1997; Patrick, 2006; She-
hata, 2011; Verma and Dubey, 2003). Im-
paired protein synthesis and inhibition of 
sulfhydryl group containing proteins, has 
been reported in lead poisoning, resulting in 
the compromise of many functional proteins 
(Devi and Banerger, 2007; Ponce-
Canchihuaman, et. al., 2010; Tkachenko and 
Kurhahyuk, 2011). Systemic damage to lipid 
metabolism has not been exempted by this 
xenobiotic, chronic toxicity of lead has been 
observed to induce hypertension and athero-
sclerosis in many subjects. Its cumulative 
adverse effects also extend to the nervous 
system, the immune system, and many vital 
organs (Erdogan, et. al., 2005; Faix, et. al., 
2005; Haleagrahara, et. al., 2011; Leonidis, et. 
al., 2010). In the kidneys precisely, chronic 
exposure to lead have been reported to trig-
ger interstitial nephritis and chronic renal 
failure, while acute exposure may give rise to 
proximal tubular dysfunctions resulting in 
glycosuria, hyperphosphaturia, and amino-
aciduria (Allouche, et. al., 2011; Muselin, et. 
al., 2010; Oteiza, et. al., 2004; Patra, et. al., 
2000; Payal, et. al., 2009). 
 
Several therapies had been introduced by 
health professionals to treat acute and 
chronic lead poisoning. Noteworthy is the 
age-long use of chelating agents such as BAL 
(British Anti Lewisite), though its use has 
long been withdrawn (Gurer and Ercal, 
2000). Other chelating agents presently still 
in use include: Calcium disodium ethyl-
enediamine tetraacetic acid (CaNa2EDTA), 
meso-2,3-dimercaptosuccinic acid (DMSA or 
Succimer), and D-Penicillamine all of whose 
mechanism of action is based on their ability 
to mobilize and chelate heavy metals such as 
lead and consequently aid their excretion 
from the body. These have always been used 
in severe cases of plumbism as the first line 
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of treatment (Flora, 2009; Flora et. al., 2004; 
Kalia and Flora, 2005). Unfortunately, other 
metals of the same valency as lead are often 
chelated as well. 
Recent reports on several research findings 
on the use of natural antioxidants, such as 
vitamin C, vitamin E and α-lipoic acid as 
therapeutic interventions in lead poisoning 
has revealed safer, promising advantageous 
and or gainful effects (Abam, et. al., 2008; 
Ademuyiwa, et. al., 2005; Bashandy, 2006; 
Gurer and Ercal, 2000; Onunkwor, et. al., 
2004; Ugbaja, et. al., 2013). They have been 
reported to reverse and/or restore lead in-
duced anomalous activities/levels of oxida-
tive stress markers such as superoxide dis-
mutase (SOD), catalase and reduced glu-
tathione (Faix, et. al., 2005; Ibrahim, et. al., 
2012). Precisely, the effectiveness of ascor-
bate has been attributed to its ability to 
scavenge or quench free radicals. It also de-
creases the intestinal absorption of lead by 
reducing ferric iron to ferrous iron in the 
duodenum, thereby increasing the availabil-
ity of iron which competes with lead for 
intestinal absorption. An increasing number 
of scientists are now advocating their use 
over conventional chelating agents as they 
generally do not have any known and or life 
threatening side effects (Kilikdar, et. al., 
2011; Koedrith and Young, 2011). 
Based on the premise that most studies on 
this xenobiotic is based on chronic expo-
sure with consequent meagre information 
on acute plumbism; and with a view to find-
ing which of the available treatments have a 
better therapeutic effect in sub-acute cases, 
whether chelating agents or natural antioxi-
dants, this research was undertaken.    
 
MATERIALS AND METHOD 
Chemicals 
Lead acetate (ACS reagent, grade >99% 
pure), diethyl ether, ammonium thiocyanate, 
ferric chloride hexahydrate and all other 
chemicals used were of analytic reagent 
grade. 
 
Experimental Design 
Thirty-five healthy male Wistar rats (150 -
200g), purchased from the Department of 
Anatomy, Faculty of Veterinary Medicine, 
University of Ibadan, Ibadan were used for 
this investigation. They were maintained at 
25oC in a well ventilated animal house on a 
12:12 hr light-dark cycle with free access to 
standard rodent laboratory chow and clean 
water ad libitum. All conditions of animal ex-
perimentation conformed with the NIH 
guidelines as outlined in NIH publication 
(National Institutes of Health, 2011). The 
rats were acclimatized for two weeks prior to 
experimental treatments. 
 
They were then randomly and evenly distrib-
uted into five groups (n=7). group 1(positive 
control)- was administered normal saline 
(0.9% NaCl),  groups 2-5 were exposed to 
75mg/kg body weight (b. wt) lead acetate 
(PbAc) daily for 14 days. Prior to therapeutic 
interventions, blood samples were collected 
by tail incision to ascertain the blood lead 
level (BLL) and catalase activity 24hours af-
ter the last PbAc exposure. Groups 2 
(negative control), 3, 4, and 5 were then 
treated with normal saline, 30mg/kg b .wt. D
-Penicillamine, 30mg/kg b. wt. meso-2,3-
dimercaptosuccinc acid (DMSA), and 
500mg/kg b. wt. Ascorbate respectively in 
two divided therapies of 5days each up to a 
total of ten days with 5 days rest in between 
the two doses to allow for lead redistribu-
tion. All administration was via oral route. 
After therapeutic interventions, all the ani-
mals were fasted overnight, subjected to light 
anaesthesia and then sacrificed. Blood sam-
ples were collected via cardiac puncture. 
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Assay of Biochemical Parameters 
Estimation of BLL 
For the estimation of the BLL, 1ml of the 
whole blood samples were acid digested and 
the BLL was then determined by atomic 
absorption spectrometry (Thermo Scientific 
S Series Atomic Absorption Spectropho-
tometer (Model Type S4 AA System) as de-
scribed by Ademuyiwa, et. al., (2005). Pre-
cisely 1ml of blood was digested with con-
centrated nitric acid and brought to a con-
stant volume. Analysis on a certified Spex, 
element standard (Spex Industries Inc., Edi-
son, New Jersey, USA) was done for exter-
nal standardization along with samples. Pro-
cedure accuracy of the lead analyses was 
evaluated by spiking control made for each 
sample and the mean recovery rate obtained 
for all analyses.  
 
Catalase activity assay 
 The catalase activity was measured by the 
method of Beers and Sizers (1952) in which 
the rate of decomposition of H2O2 was 
measured spectrophotometrically from 
changes in absorbance at 240nm. 2.0 ml of 
phosphate buffer diluted whole blood was 
added to cuvette. Reaction was initiated by 
the addition of 1.0 ml of freshly prepared 
0.059M H2O2. One unit is equal to one 
micromole of hydrogen peroxide decom-
posed per minute under specified condi-
tions at 25oC. Activity of catalase is ex-
pressed as units/ml. 
 
Xanthine oxidase assay 
The activity of Xanthine oxidase (XO) in 
the plasma was determined using the spec-
trophotometric method described in the 
Worthington Enzyme Manual (2008). The 
rate of formation of urate from hypoxan-
thine is determined by measuring increased 
absorbance at 290 nm.  A unit of activity is 
that forming one micromole of urate per 
minute at 25°C. 
From the blood sample, the plasma was 
separated by centrifugation, aliquoted into 
eppendorf tubes and frozen until analysis. 
The plasma concentration of alanine transa-
minase (ALT), aspartate transaminase (AST), 
blood urea nitrogen (BUN) and creatinine 
were determined spectrophotometrically us-
ing Cypress diagnostic kits. 
 
 Statistical Analysis 
The results obtained were Mean ± Standard 
Error of Mean (SEM). One-way Analysis of 
Variance (ANOVA) test was performed to 
check the significance of differences among 
the groups followed by Duncan’s post hoc 
test to compare the treated groups with the 
control group. Values of p<0.05 were re-
garded as significant, using the Statistical 
Package for Social Sciences (SPSS) version 
16.0. 
 
RESULTS 
Blood Lead Levels (BLL) 
While the concentration of lead in the con-
trol remained insignificantly different 
throughout the period of experiment, 
marked changes were recorded in the BLL 
of the other four groups. The three groups 
administered therapeutics showed a signifi-
cant decrease in the BLL by 33% on the av-
erage with the DSMA being most effective. 
The negative control group administered 
lead only, showed no significant change in 
the level of lead in the blood (Fig. 1).  
 
Catalase activity before and after thera-
peutic treatment 
Prior to therapeutic interventionss, catalase 
activity in the whole blood decreased signifi-
cantly in all the four groups orally exposed to 
lead acetate (95.95±4.31 U/mL, 86.36±5.01 
U/mL, 98.99±7.69 U/mL and 88.47±13.65 
U/mL) compared to that of the control 
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group (149.55±7.5 U/mL) at p<0.05. How-
ever, the administration of chelating agents 
and ascorbate to groups 3, 4, and 5 thereaf-
ter reversed the lead induced decreased ac-
tivity significantly P<0.05 elevating blood 
catalase activity by two folds (189.57±11.79 
U/mL, 197.99±10.60 U/mL and 
216.95±30.13 U/mL respectively), as shown 
in Fig. 2. The order of most significant in-
crease was ascorbate > penicillamine  > 
 succimer. 
Fig. 1: Blood lead levels before and after therapeutic intervention. Bars not having any   
            letter (a-e) in common are significantly different (p < 0.05).   
Fig. 2: Blood catalase and xanthine oxidase activities before and after therapeutic  
            intervention. Bars not having any letter (a-c) in common are significantly different   
             (p < 0.05).             
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Fig. 3: Plasma ALT and AST activities after therapeutic intervention. Bars not having    
            any letter (a-d) in common are significantly different (p < 0.05). 
Fig. 4: Plasma urea and creatinine levels after therapeutic intervention. Bars not having   
            any letter (a-c) in common are significantly different (p < 0.05).  
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Xanthine oxidase (XO) activity in the 
plasma 
All four groups treated with lead had a sig-
nificantly high level of plasma XO (1.18 ± 
0.01, 0.85 ± 0.02, 0.74 ± 0.03 and 0.76 ± 
0.01 U/dl respectively) at p<0.05 when 
compared with the control group (0.56 ± 
0.01 U/dl); Fig. 2. The therapeutics admin-
istered had no significant effect on the 
plasma level of XO (p>0.05). 
 
Alanine transaminase (ALT) and Aspar-
tate transaminase (AST) activities in the 
plasma 
The activities of ALT and AST in the 
plasma were observed to be significantly 
higher (p<0.05) in the group administered 
lead only (79.17 ± 3.30 U/L and 271.67 ± 
0.71 U/L respectively) when compared with 
the control group (33.71 ± 2.68 U/L and 
137.22 ± 1.87 U/L respectively) and the 
three groups thereafter administered with 
therapeutic agents. However, of the groups 
administered therapeutics, the group admin-
istered ascorbate had the least activities of 
these liver marker enzymes (59.08 ± 2.55 
U/L and 143.42 ± 2.42 U/L respectively) in 
the plasma, Fig. 3. 
 
Blood urea nitrogen (BUN) and 
creatinine concentration in the plasma 
The assay results obtained for the rats’ kid-
ney function followed a similar trend as ob-
served for the liver marker enzymes; the 
concentrations of urea and creatinine in the 
plasma were significantly lower (p<0.05) in 
the groups administered with the therapeu-
tics. The group administered ascorbate had 
the least urea and creatinine concentration 
in the plasma (6.31 ± 0.38 mg/dl and 0.89 
± 0.06 mg/dl respectively), when compared 
with the lead only group: 9.43 ± 0.45 mg/dl 
and 2.51 ± 0.31 mg/dl respectively, as indi-
cated in Fig. 4. 
DISCUSSION 
Sub-acute lead poisoning has been found to 
present more severe clinical symptoms in the 
population, hence this study evaluated the 
relative effectiveness of chelating agents and 
natural antioxidants in cases of plumbism 
using D-Penicillamine, DMSA and  
Ascorbate.  
 
Oral route of administering lead acetate was 
preferred in this study because of earlier re-
ports that the accumulation of lead in vital 
organs, like the liver and kidney, was signifi-
cant upon ingestion (Muselin, et. al., 2010). 
This was confirmed in this study; there was a 
significant increase (p<0.05) in the BLL of 
all groups administered lead acetate com-
pared to the positive control group. Lead 
ingestion is common among children be-
cause most of their toys contain a form of 
lead coating (Nriagu, et. al., 1997; Stravreva-
Veselinovska and Ziranovic, 2010; Zhang, et. 
al., 2012). The significant presence of this 
metal in such vital organs may be as a result 
of the body’s self-effort to excrete the poi-
son since the liver is especially known for its 
role in detoxification, and the kidney in ex-
cretion (Patra, et. al., 2000). 
 
Much widely known effect of lead toxicity is 
oxidative stress. Oxidative stress is a broad 
term referring to several changes in vivo such 
as the presence of free reactive oxygen or 
nitrogen species, decrease in the count or 
activity of antioxidants and antioxidant en-
zymes, increased lipid peroxidation, among 
others (Raafat, et. al., 2009). One of the ma-
jor concepts in the mechanism of heavy 
metal toxicity is attributed to its ability to 
generate reactive oxygen species which cause 
peroxidation of lipids (Draper et al., 1993; 
Ademuyiwa, et. al., 2005; Bashandy, 2006; 
Harishekar and Kiran, 2011). 
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Catalase is an important antioxidant enzyme 
which helps in decomposing the reactive 
hydrogen peroxide to less deleterious water 
and oxygen (Kilikdar, et. al., 2011). In this 
study, lead toxicity significantly reduced the 
activity of catalase, therefore indicating that 
free radicals are generated in lead poisoning. 
The plausible reason for decreased catalase 
activity is that as more free reactive oxygen 
species, especially H2O2, were generated, 
more molecules of catalase were involved in 
peroxide breakdown, leading to a transient 
exhaustion of the catalase pool (Gurer, et. 
al., 1999; Sujatha, et. al., 2011; Verma and 
Dubey, 2003). Therapeutic intervention 
however reversed this trend in the order 
ascorbate > penicillamine > succimer. Sev-
eral mechanisms have also been proposed 
to explain this reversal; but the much em-
phasized is that chelating agents and anti-
oxidants alike have the ability to chelate lead 
out of the system, that is they form an easily 
excretable complex with lead (Haleagrahara, 
et. al., 2011). Others attribute the reversal to 
the fact that most antioxidants work syner-
gistically with enzymes such as catalase that 
are involved in reversal of oxidative stress. 
The values obtained when related with lead 
induced lipid peroxidation-though reported 
elsewhere, were consistent with that of cata-
lase (Ugbaja, et. al., 2013). This confirms 
that lead poisoning induces oxidative stress 
and brings about a consequent increase in 
lipid peroxidation and a decrease in the ac-
tivity of catalase (Tkachenko and Kurha-
hyuk, 2011). 
 
For catalase activity, the degree of effective-
ness for each therapeutic administered dif-
fered significantly. Catalase activity in the 
therapeutic treated groups increased signifi-
cantly (p<0.05), and the group administered 
ascorbate had the most positive numerical 
difference in catalase activity. Comparing 
the results obtained on the oxidative stress 
markers, it becomes clear that: first, ascor-
bate remains a very potent antioxidant 
against oxidative stress, in the event of lead 
poisoning. Ascorbate is able to prevent oxi-
dative stress better probably because it elicits 
mechanisms that can prevent the generation 
of the free radicals before they accumulate 
(Raafat, et. al., 2009). In other words, ascor-
bate is more of a scavenger than a chelator. 
Secondly, it is probable that chelating agents, 
like D-Penicillamine may be involved in 
some latent co-generation of free radicals 
(reactive nitrogen species) when adminis-
tered beyond a certain dosage (Kilikdar, et. 
al., 2011). 
 
Xanthine oxidase is a pro-oxidative enzyme 
that measures the rate of conversion of hy-
poxanthine to xanthine and then to uric acid 
(Zhang, et. al., 2010). An increased activity of 
this enzyme is considered to indicate in-
creased rate of oxidative stress due to forma-
tion of superoxide anion free radicals 
(Kilikdar, et. al., 2011; Zhang, et. al., 2010). 
Therefore, lead as a potential initiator of free 
radical generation mechanism should signifi-
cantly increase the plasma level of xanthine 
oxidase. The result obtained from the group 
administered lead only when compared with 
the control group proves this. The inability 
of the therapeutic agents to reduce plasma 
XO levels may imply that there is still a sig-
nificant free radical generation in some body 
compartments. It could also be that there is a 
rather slow response of XO to therapeutics 
once elevated, more so it is nucleotide re-
lated.   
 
The accumulation of heavy metals such as 
lead has been known to be a notable cause 
of liver, kidney and brain damage 
(Hamadouche, et. al., 2009; Moreira, et. al., 
2001; Stravreva-Veselinovska and Ziranovic, 
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2010; Tkachenko and Kurhahyuk, 2011). 
When the liver is damaged, it often results 
to a marked increase in the activities of the 
enzymes that are more confined within the 
hepatic cells. Such enzymes include alanine 
transaminase (ALT) and aspartate transami-
nase (AST), and so are marker enzymes to 
estimate the extent of damage in the liver. 
Lead is known to promote oxidative dam-
age in liver by enhancing peroxidation of 
membrane lipids, a deleterious process car-
ried out by free radicals most likely released 
by the auto-oxidation of accumulated amino 
levulinic acid due to inhibition of amino 
levulinic acid dehydratase (Balali-Mood, et. 
al., 2010; Bashandy, 2006; Costa, et. al., 
1997; Gurer, et. al., 1999; Patrick, 2006).  
Some reports attribute the liver damage pe-
culiar to plumbism to the fact that lead 
binds to plasma proteins and is conducted 
to liver, where it causes alterations in high 
number of enzymes. It can also perturb 
protein biosynthesis in hepatocytes, includ-
ing the structural proteins (Shalan, et. al., 
2005).  
 
Over-production of free radicals following 
lead exposure initiates from mitochondria 
and spreads out quickly to all cellular and 
tissue components, causing dysfunction in 
cellular energy metabolism, membrane 
transportation and finally cell death. An-
other potent source of free radicals in the 
liver can be kupffer cells (Chen, et. al., 
2003). In response to oxidative stress in-
duced by lead, endogenous antioxidants are 
consumed resulting in continuously de-
creasing tissue and cellular anti-oxidative 
capacity that leads to progressive oxidative 
injury (Bashandy, 2006; Patra, et. al., 2011; 
Shehata, 2011).  
 
Upon administration of therapeutics, the 
chelating agents showed a poor therapeutic 
response. D-Penicillamine and succimer 
were unable to restore normal AST levels in 
the blood significantly (p<0.05). This may be 
because AST is not so specific for liver func-
tion, and so its relatively persistent high lev-
els in the plasma may be an indicator that 
some other organ, asides liver, is still being 
adversely affected in the body. 
 
These heavy metals also affect the major or-
gan of excretion- the kidneys. They affect 
the renal efficiency in the removal of poten-
tially toxic metabolites such as urea, thus 
making the metabolites to be found in con-
centrations far higher than normal in vivo 
(Ponce-Canchihuaman, et. al., 2010). In the 
kidneys precisely, chronic exposure to lead 
have been reported to trigger interstitial ne-
phritis and chronic renal failure, while acute 
exposure may give rise to proximal tubular 
dysfunction with glycosuria, hyperphos-
phaturia, and aminoaciduria (Allouche, et. al., 
2011; Muselin, et. al., 2010). 
 
Kidney function was acutely affected by lead 
poisoning as well, but the use of chelating 
agents could not effectively correct the re-
sulting kidney dysfunction. This is consistent 
with some report that chelators, though can 
reduce the BLL, they do not reverse most 
impairment caused by lead on systems and 
organs especially in children (Shannon, et. al., 
2005). The group administered ascorbate 
however showed a remarkable therapeutic 
effect by significantly restoring the plasma 
level of both the liver and kidney marker en-
zymes- ALT, AST, BUN and creatinine to 
near that of the control group. It implies 
therefore that there could be a positive link 
between ascorbate’s scavenging property for 
free radicals and its ability to regulate blood 
plasma parameters about the normal range 
(Erdogan, et. al., 2005; Raafat, et. al., 2009).  
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Ascorbate has proved most effective in mo-
bilizing lead from the liver and kidney as 
observed in this study. Though this may not 
be generalization in vivo; more studies must 
be done to ascertain the effectiveness of 
ascorbate in mobilizing lead from other vi-
tal tissues and organs like the bones. This is 
necessary on the premise that a large per-
centage of this metal on exposure becomes 
stored in the bones. This may throw more 
light on the mechanism behind calcium loss 
from the bones partly due to the presence 
of divalent ions like lead and how it can be 
alleviated. 
 
CONCLUSION 
This experiment has again indicated that 
lead poisoning inevitably leads to oxidative 
stress, and the dysfunction of vital organs 
such as the liver and kidney. Ascorbate has 
proved most efficacious in managing the 
effects of sub-acute lead poisoning such as 
oxidative stress and organ dysfunction. 
Since most antioxidants work synergistically 
with one another, ascorbate might have 
proved effective because of some other an-
tioxidants present in the body of the animal 
subjects. Therefore, more study must be 
done to confirm ascorbate’s independent 
efficacy, else the use of co-administration to 
mimic antioxidants’ synergistic interaction 
that occur in vivo. 
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